Current Infectious Disease Reports

, Volume 11, Issue 2, pp 120–124 | Cite as

The expanding spectrum of disease due to Salmonella: An international perspective

Article

Abstract

Human disease due to Salmonella infections appears to be on the rise worldwide. Despite the availability of vaccines and generally effective antibiotic therapy, salmonellosis, in the forms of gastroenteritis and enteric fever, remains a major cause of morbidity and mortality in many developing countries, especially in young children and immunocompromised hosts. In certain highly endemic areas of South and Southeast Asia, the emergence of quinolone-resistant and multidrug-resistant strains of Salmonella contribute to the magnitude of the problem. In the United States and Europe, a low but consistent rate of disease appears to be primarily related to ingestion of contaminated poultry, lapses in sanitary agricultural practices, and importation of tainted vegetable products. An improved understanding of the molecular basis of bacterial resistance and improved design and expanded use of vaccines provide hope for containing the spread and reducing morbidity of the international spectrum of disease due to Salmonella pathogens.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Parry CM, Hien TT, Dougan G, et al.: Typhoid fever. N Engl J Med 2002, 347: 1770–1782.PubMedCrossRefGoogle Scholar
  2. 2.
    Crum NF: Current trends in typhoid fever. Curr Gastroenterol Rep 2003, 5: 279–286.PubMedCrossRefGoogle Scholar
  3. 3.
    Bhan MK, Bahl R, Bhatnagar S: Typhoid and paratyphoid fever. Lancet 2005, 366: 749–762.PubMedCrossRefGoogle Scholar
  4. 4.
    Bhutta ZA: Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006, 333: 78–82.PubMedCrossRefGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention (CDC): Outbreak of Salmonella serotype Saintpaul infections associated with multiple raw produce items-United States, 2008. MMWR Morb Mortal Wkly Rep 2008, 57: 929–934.Google Scholar
  6. 6.
    European Food Safety Authority: The Community Summary Report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2006. The EFSA Journal 2007, 130: 11–352. Available at http://www.efsa.europa.eu/cs/BlobServer/DocumentSet/Zoon_report_2006_en,0.pdf?ssbinary=true. Accessed December 2008.Google Scholar
  7. 7.
    Schmid H, Hächler H, Stephan R et al.: Outbreak of Salmonella enterica serovar Typhimurium in Switzerland, May–June 2008, implications for production and control of meat preparations. Euro Surveill 2008, 13(44):pii=19020. Available at http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19020. Accessed December 2008.
  8. 8.
    Westrell T: Salmonella Typhimurium: experiences from recent European outbreaks. Euro Surveill 2008, 13(44): pii=19019. Available at http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19019. Accessed December 2008.
  9. 9.
    Crump JA, Luby SP, Mintz ED: The global burden of typhoid fever. Bull World Health Organ 2004, 82: 346–353.PubMedGoogle Scholar
  10. 10.
    Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al.: A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 2008, 86: 260–268.PubMedCrossRefGoogle Scholar
  11. 11.
    Maskey AP, Basnyat B, Thwaites GE, et al.: Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993–2003. Trans R Soc Trop Med Hyg 2008, 102: 91–95.PubMedCrossRefGoogle Scholar
  12. 12.
    Crump JA, Ram PK, Gupta SK, et al.: Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984–2005. Epidemiol Infect 2008, 136: 436–448.PubMedCrossRefGoogle Scholar
  13. 13.
    DeRoeck D, Ochiai RL, Yang J, et al.: Typhoid vaccination: the Asian experience. Expert Rev Vaccines 2008, 7: 547–560.PubMedCrossRefGoogle Scholar
  14. 14.
    Ohl ME, Miller SI: Salmonella: a model for bacterial pathogenesis. Annu Rev Med 2001, 52: 259–274.PubMedCrossRefGoogle Scholar
  15. 15.
    Francis CL, Starnbach MN, Falkow S: Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions. Mol Microbiol 1992, 6: 3077–3087.PubMedCrossRefGoogle Scholar
  16. 16.
    Gordon MA: Salmonella infections in immunocompromised adults. J Infect 2008, 56: 413–422.PubMedCrossRefGoogle Scholar
  17. 17.
    Woodward TE SJ, Ley HL et al.: Preliminary report on the beneficial effect of chloromycetin in the treatment of typhoid fever. Ann Intern Med 1948, 29: 131–134.PubMedGoogle Scholar
  18. 18.
    Mirza SH, Beeching NJ, Hart CA: Multi-drug resistant typhoid: a global problem. J Med Microbiol 1996, 44: 317–319.PubMedCrossRefGoogle Scholar
  19. 19.
    Su LH, Chiu CH, Chu C, Ou JT: Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 2004, 39: 546–551.PubMedCrossRefGoogle Scholar
  20. 20.
    Okeke IN, Laxminarayan R, Bhutta ZA, et al.: Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005, 5: 481–493.PubMedCrossRefGoogle Scholar
  21. 21.
    Kumar S, Rizvi M, Berry N: Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008, 57: 1247–1250.PubMedCrossRefGoogle Scholar
  22. 22.
    Parry CM, Threlfall EJ: Antimicrobial drug resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 2008, 21: 531–538.PubMedCrossRefGoogle Scholar
  23. 23.
    Rodrigues C, Shenai S, Mehta A: Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis 2003, 36: 535.PubMedCrossRefGoogle Scholar
  24. 24.
    Mills-Robertson F, Addy ME, Mensah P, Crupper SS: Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana. FEMS Microbiol Lett 2002, 215: 249–253.PubMedCrossRefGoogle Scholar
  25. 25.
    Gales AC, Sader HS, Mendes RE, Jones RN: Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997–2000). Diagn Microbiol Infect Dis 2002, 44: 313–318.PubMedCrossRefGoogle Scholar
  26. 26.
    Helms M, Ethelberg S, Molbak K: International Salmonella typhimurium DT104 infections, 1992–2001. Emerg Infect Dis 2005, 11: 859–867.PubMedGoogle Scholar
  27. 27.
    Ribot EM, Wierzba RK, Angulo FJ, Barrett TJ: Salmonella enterica serotype Typhimurium DT104 isolated from humans, United States, 1985, 1990, and 1995. Emerg Infect Dis 2002, 8: 387–391.PubMedGoogle Scholar
  28. 28.
    Threlfall EJ, Fisher IS, Berghold C, et al.: Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill 2003, 8: 41–45.PubMedGoogle Scholar
  29. 29.
    Gaind R, Paglietti B, Murgia M, et al.: Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemother 2006, 58: 1139–1144.PubMedCrossRefGoogle Scholar
  30. 30.
    Chau TT, Campbell JI, Galindo CM, et al.: Antimicrobial drug resistance of Salmonella enterica serovar typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 2007, 51: 4315–43123.PubMedCrossRefGoogle Scholar
  31. 31.
    Thaver D, Zaidi AK, Critchley J, et al.: Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2006, 1:CD004530.Google Scholar
  32. 32.
    Parry CM: The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 2004, 98: 413–422.PubMedCrossRefGoogle Scholar
  33. 33.
    Parry CM, Ho VA, Phuongle T, et al.: Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007, 51: 819–825.PubMedCrossRefGoogle Scholar
  34. 34.
    Frenck RW Jr, Nakhla I, Sultan Y, et al.: Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 2000, 31: 1134–1138.PubMedCrossRefGoogle Scholar
  35. 35.
    Guzman CA, Borsutzky S, Griot-Wenk M, et al.: Vaccines against typhoid fever. Vaccine 2006, 24: 3804–3811.PubMedCrossRefGoogle Scholar
  36. 36.
    Fraser A, Paul M, Goldberg E, et al.: Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine 2007, 25: 7848–7857.PubMedCrossRefGoogle Scholar
  37. 37.
    DeRoeck D, Clemens JD, Nyamete A, Mahoney RT: Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 2005, 23: 2762–2774.PubMedCrossRefGoogle Scholar
  38. 38.
    DeRoeck D, Jodar L, Clemens J: Putting typhoid vaccination on the global health agenda. N Engl J Med 2007, 357: 1069–1071.PubMedCrossRefGoogle Scholar
  39. 39.
    World Health Organization: Typhoid vaccines: WHO position paper. Wkly Epidemiol Rec 2008, 83: 49–60.Google Scholar
  40. 40.
    Lin FY, Ho VA, Khiem HB, et al.: The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-yearold children. N Engl J Med 2001, 344: 1263–1269.PubMedCrossRefGoogle Scholar
  41. 41.
    Kirkpatrick BD, McKenzie R, O’Neill JP, et al.: Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine 2006, 24: 116–123.PubMedCrossRefGoogle Scholar
  42. 42.
    Zhang XL, Jeza VT, Pan Q: Salmonella typhi: from a human pathogen to a vaccine vector. Cell Mol Immunol 2008, 5: 91–97.PubMedCrossRefGoogle Scholar
  43. 43.
    Spano S, Galan JE: A novel pathway for exotoxin delivery by an intracellular pathogen. Curr Opin Microbiol 2008, 11: 15–20.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Division of Infectious Diseases and HIV MedicineClevelandUSA

Personalised recommendations